Regain control of drug spend in 2022: 3 pharmacy benefits trends to watch
- Dec 29, 2021
- PBM Model
The pandemic raised new concerns about medication access and supply, both of which drove utilization and costs upward. Centers for Medicare & Medicaid Services (CMS) projects prescription spend for commercial plans will grow an average of 5% annually, meanwhile, plan sponsors continue to battle budget pressures and ambiguity over their spend. And the benefit needs of member populations have changed because of the pandemic, once again putting pharmacy benefits under the microscope for 2022.
Read more by clicking the link to the full article below.